中国医药导报2016,Vol.13Issue(33) :34-38.

SDF-1/CXCR4轴与肿瘤转移研究进展

Research progress of SDF-1/CXCR4 axis and tumor metastasis

杨永 于明薇 杨国旺 王笑民 许炜茹
中国医药导报2016,Vol.13Issue(33) :34-38.

SDF-1/CXCR4轴与肿瘤转移研究进展

Research progress of SDF-1/CXCR4 axis and tumor metastasis

杨永 1于明薇 2杨国旺 2王笑民 2许炜茹2
扫码查看

作者信息

  • 1. 北京中医药大学,北京100029
  • 2. 首都医科大学附属北京中医医院肿瘤科,北京100010
  • 折叠

摘要

趋化因子及其受体被认为在肿瘤转移中发挥重要作用,SDF-1及其受体CXCR4目前研究较多.CXCR4在多种高转移肿瘤中高表达,SDF-1/CXCR4轴可激活多种信号通路,参与肿瘤的侵袭与转移,可提高细胞运动、迁移与侵袭能力,促进基质降解,细胞间黏附及血管生成.提示精准干预SDF-1/CXCR4轴从而抑制肿瘤转移,具有潜在临床应用前景.

Abstract

Chemokines and their receptors are thought to play an important role in tumor metastasis.SDF-1 and its receptor CXCR4 are currently studied.CXCR4 is highly expressed in high metastatic tumors.SDF-1/CXCR4 axis can activate avariety of signaling pathways involved in tumor invasion and metastasis,which can enhance cell motility,migration and invasion ability,promote matrix degradation,cell adhesion and angiogenesis.It is suggested that the precision intervention of SDF-1/CXCR4 biological axis can inhibit tumor metastasis,which has potential clinical application prospects.

关键词

SDF-1/CXCR4/肿瘤转移/研究进展

Key words

SDF-1/CXCR4/Tumor metastasis/Research progress

引用本文复制引用

基金项目

国家自然科学基金(81503517)

北京市医院管理局青年人才培养“青苗”计划项目(QML20161001)

出版年

2016
中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
被引量3
参考文献量2
段落导航相关论文